Translocator protein (18 kDa)(TSPO) as a therapeutic target for neurological and psychiatric disorders

R Rupprecht, V Papadopoulos, G Rammes… - Nature reviews Drug …, 2010 - nature.com
Abstract The translocator protein (18 kDa)(TSPO) is localized primarily in the outer
mitochondrial membrane of steroid-synthesizing cells, including those in the central and …

Phosphodiesterase inhibitors for Alzheimer's disease: a systematic review of clinical trials and epidemiology with a mechanistic rationale

O Sanders, L Rajagopal - Journal of Alzheimer's Disease …, 2020 - content.iospress.com
Background: Preclinical studies, clinical trials, and reviews suggest increasing 3', 5'-cyclic
adenosine monophosphate (cAMP) and 3', 5'-cyclic guanosine monophosphate (cGMP) with …

Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine—a PDE1 inhibitor

R Deshmukh, V Sharma, S Mehan, N Sharma… - European journal of …, 2009 - Elsevier
Enhancing cyclic nucleotides signaling by inhibition of phosphodiesterases (PDEs) is known
to be beneficial in disorders associated with cognitive decline. The present study was …

Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma

V Papadopoulos, L Lecanu - Experimental neurology, 2009 - Elsevier
Traumatic brain injury (TBI) induces physical, cognitive, and psychosocial deficits that affect
millions of patients. TBI activates numerous cellular mechanisms and molecular cascades …

New insights on the potential effect of vinpocetine in Parkinson's disease: one of the neglected warden and baffling topics

HM Al-Kuraishy, A Alexiou, M Papadakis… - Metabolic Brain …, 2023 - Springer
Vinpocetine (VPN) is an ethyl apovincaminate that has anti-inflammatory and antioxidant
effects by inhibiting the expression of nuclear factor kappa B (NF-κB) and …

Role of vinpocetine in cerebrovascular diseases

S Patyar, A Prakash, M Modi, B Medhi - Pharmacological Reports, 2011 - Springer
A cerebrovascular accident, or stroke, is defined as the abrupt onset of a neurological deficit,
which can be due to ischemia. Cerebral ischemia is caused by a reduction in blood flow that …

Anti-inflammatory effects of vinpocetine in atherosclerosis and ischemic stroke: a review of the literature

L Zhang, L Yang - Molecules, 2014 - mdpi.com
Immune responses play an important role in the pathophysiology of atherosclerosis and
ischemic stroke. Atherosclerosis is a common condition that increases the risk of stroke …

Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C] vinpocetine

B Gulyás, Á Vas, M Tóth, A Takano, A Varrone… - Neuroimage, 2011 - Elsevier
BACKGROUNDS AND PURPOSE: The main objectives of the present study were (i) to
measure density changes of activated microglia and the peripheral benzodiazepine …

Effect of piracetam, vincamine, vinpocetine, and donepezil on oxidative stress and neurodegeneration induced by aluminum chloride in rats

OME Abdel-Salam, SM Hamdy, SAM Seadawy… - Comparative Clinical …, 2016 - Springer
In this study, we investigated the effects of the memory-enhancing drugs piracetam,
vincamine, and vinpocetine or the cholinesterase inhibitor donepezil on the development of …

AUTEN-67, an autophagy-enhancing drug candidate with potent antiaging and neuroprotective effects

D Papp, T Kovács, V Billes, M Varga, A Tarnóci… - Autophagy, 2016 - Taylor & Francis
abstract Autophagy is a major molecular mechanism that eliminates cellular damage in
eukaryotic organisms. Basal levels of autophagy are required for maintaining cellular …